The Healthcare business of Thomson Reuters helps pharmaceutical and biotechnology companies make sound business decisions regarding product lifecycle development, positioning, and value to stakeholders by providing unbiased, third-party research and information grounded in real-world healthcare data.

Research Services
We provide outcomes, market, and epidemiology research to assist clients in understanding market opportunities, optimal positioning, safety, and value for their products. Our research has a reputation for rigorous data development and leading-edge analytics, meeting the highest professional standards.

MarketScan Research Databases
The MarketScan Family of Research Databases, a suite of robust and clinically rich, de-identified datasets, allows researchers to gain real-world insights across the complete spectrum of healthcare delivery. The gold-standard claims databases provide access to fully integrated patient-level, clinical, financial, and pharmaceutical cost and utilization information for the U.S. commercially insured, Medicare Supplemental, and Medicaid populations. Sister databases include fully integrated health and productivity data, health risk assessment data, laboratory results, hospital discharge, and linked hospital drug – outpatient drug data. Micromedex® solutions for Medication Safety and Nexcura® patient communities for selected diseases offer unique datasets to enhance research using the MarketScan databases.

PULSE Healthcare Survey
The annual PULSE survey allows pharmaceutical researchers to conduct patient surveys at a fraction of the cost of stand-alone projects.  PULSE, the nation's largest, privately funded, consumer healthcare survey, reaches out to 100,000 U.S. households annually.

Clinical Trial Recruitment
Clinical Trial Solutions enable clinical trial administrators to identify qualified investigators and recruit patients quickly and efficiently through the application of real-world healthcare data.